OECD proposes new rules for multinational drug studies

02/27/2013 | PharmaTimes (U.K.)

The Organization for Economic Co-operation and Development has called on member nations to harmonize their rules for risk management of multinational clinical trials run by universities, hospitals and other nonprofit organizations. Such noncommercial drug trials increasingly involve study sites in multiple countries, and differing national regulations can raise barriers and costs.

View Full Article in:

PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC